Title: FDA Authorizes Pfizer and Moderna mRNA COVID-19 Boosters to Combat XBB. 1.5 Variant
In a significant development in the ongoing battle against COVID-19, the U.S. Food and Drug Administration (FDA) has granted authorization for updated versions of the Pfizer and Moderna mRNA vaccines to be used as boosters. This decision comes amidst concerns over the highly transmissible XBB. 1.5 variant, one of the most prevalent strains of the virus during this season.
In accordance with the FDA’s authorization, the Centers for Disease Control and Prevention (CDC) has recommended the booster shots for everyone over the age of six months, with a few exceptions for individuals who have recently recovered from COVID-19 or have been recently boosted. However, the CDC strongly advises individuals at high risk, including those over the age of 65 and individuals with underlying health conditions, to receive the booster.
Experts have noted that despite prior vaccination or infection, the risk of contracting COVID-19 again increases over time as new variants emerge and vaccine immunity diminishes. The booster shots, therefore, play a vital role in preventing severe illness, reducing the likelihood of long COVID, and ensuring continual protection as immunity naturally wanes.
Critics, however, have voiced their concerns regarding the CDC’s recommendation. Some experts argue that the focus should be primarily on providing boosters to the most vulnerable groups within the population.
To make the booster shots easily accessible, health insurance coverage will include the cost for the majority of Americans. Furthermore, for those without insurance, the federal Bridge Access Program will cover the expense. Pfizer and Moderna have set the list price of their vaccines at $120 and $129, respectively.
The FDA’s authorization of Pfizer and Moderna’s COVID-19 vaccine boosters marks a significant step in the fight against the XBB. 1.5 variant. The CDC’s endorsement of booster shots for the majority of the population, along with insurance coverage and the Bridge Access Program, aims to ensure that this additional layer of protection reaches those who need it most.
As the pandemic continues to evolve, staying informed and following official healthcare guidance will be critical in our collective efforts to mitigate the spread of COVID-19 and protect public health.
“Travel aficionado. Incurable bacon specialist. Tv evangelist. Wannabe internet enthusiast. Typical creator.”